Monoclonal antibody drug Vedolizumab®. An anti-integrin therapy with a selective mechanism of action, for use in primary types of inflammatory bowel disease — ulcerative colitis and Crohn's disease.
Part of a series; Drug's mechanism of action graphics at cellular level for pharmaceutical project.
Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management
Keywords: Line with Color, Action, Corporate, Education, Health, Information Graphics, Medical, Product, Science, Scientific
© Mica Duran